Each area of research at CoDES have shared interest of using big data, but also include a broader spectrum of drug safety initiatives that address how medications are used, misused and abused.
Dr. Wei led a study that questions the accuracy of CMS criteria for flagging patients as at risk for opioid abuse and overdose.
Primary Research Areas
Evaluate drug safety and effectiveness in real-world populations to enhance pre-approval evidence
Asses the value of drugs and related programs to guide investment of personal, payer and societal resources
Evaluate the quality and determinants of medication use to direct allocation of resources and policy
Develop predictive tools for drug response and adverse events to support clinical care and related policy
Evaluate policy surrounding medication use to enhance programmatic efforts aimed to improve access and quality of drug therapy